Michael Goldberg | CEO |
Jed Latkin | CFO and COO |
Brian Brennan | National Securities |
Good day and welcome to the Navidea Biopharmaceuticals analyst conference call. Today's conference is being recorded. At this time, I would like to turn the conference over to Jed Latkin, Chief Financial and Chief Operating Officer. Please go ahead, sir.
Thank you, Emily and welcome, everyone, to this morning's earnings conference call.